Michael Yang
Fortune : 1 M $ au 31/05/2026
Fortune : 1 M $ au 31/05/2026
Michael J.
Yang is currently an Independent Director at Ionis Pharmaceuticals, Inc. and Pacira Biosciences, Inc., both since 2023, and an Operating Partner at ARTIS Ventures Management LP.
Former roles include President, Chief Executive Officer & Director at ViaCyte, Inc. (2021–2022); Director at Akcea Therapeutics, Inc. (2020); President at Johnson & Johnson; Chief Commercial Officer & Executive Vice President at ACADIA Pharmaceuticals, Inc. (2017–2021); Vice President-Sales & Marketing at Ortho Biotech, Inc.; General Manager at Veridex LLC and Therakos LLC; President at Janssen Biotech, Inc.; and President-Immunology at Janssen Pharmaceuticals, Inc. (2013–2017).
Education includes undergraduate studies at San Diego State University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/07/2026 | 7 940 ( 0 % ) | 607 410 $ | 31/05/2026 | |
PACIRA BIOSCIENCES, INC. 0,05 % | 10/06/2026 | 19 798 ( 0,05 % ) | 459 710 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| PACIRA BIOSCIENCES, INC. | Directeur/Membre du Conseil | 10/10/2023 |
| IONIS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 14/12/2023 |
ARTIS Ventures Management LP
ARTIS Ventures Management LP Investment ManagersFinance ARTIS Ventures seeks investment opportunities in companies located in the United states. The firm focuses on a broad range of sectors and industries. It participates in early stage capital transactions. | Private Equity Investor | - |
| Sociétés | Poste | Fin |
|---|---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Directeur Général | 01/10/2022 |
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 29/01/2021 |
| AKCEA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/12/2020 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Corporate Officer/Principal | 01/03/2017 |
| JOHNSON & JOHNSON | President | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 13 |
|---|---|
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
ACADIA Pharmaceuticals, Inc.
ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Health Technology |
Ortho Biotech, Inc. | |
Veridex LLC
Veridex LLC Medical SpecialtiesHealth Technology Supplies vitro diagnostic oncology products | Health Technology |
Pacira Biosciences, Inc.
Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
San Diego State University
San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Therakos, Inc.
Therakos, Inc. BiotechnologyHealth Technology Develops extracorporeal photopheresis delivery system for autologous immunomodulatory therapy | Health Technology |
Janssen Biotech, Inc.
Janssen Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
ARTIS Ventures Management LP
ARTIS Ventures Management LP Investment ManagersFinance ARTIS Ventures seeks investment opportunities in companies located in the United states. The firm focuses on a broad range of sectors and industries. It participates in early stage capital transactions. | Finance |
Akcea Therapeutics, Inc.
Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for cardiometabolic lipid disorders | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national